Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at SGD 268.7B, ahead of Johnson & Johnson (SGD 257.2B) and Sanofi (SGD 181.6B). Figures as of 19 Nov 2026, 22:37 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSGD 268.7B
- Median
- SGD 4.5B
- Combined market value
- SGD 6.41T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SGD 268.7B | SGD 202.7B | SGD 35.56 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SGD 257.2B | SGD 830.3B | SGD 344.89 | 2.04% down | 34% up | ||
| 3 | SanofiSNY · Health Care | SGD 181.6B | SGD 142.8B | SGD 59.47 | 2.25% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SGD 176.7B | SGD 422.7B | SGD 171.46 | 3.61% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | SGD 172.9B | SGD 647.1B | SGD 366.06 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SGD 147.3B | SGD 351.2B | SGD 226.46 | 1.87% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | SGD 145.2B | SGD 1.55T | SGD 1,744.36 | 2.29% down | 33% up | ||
| 8 | NovartisNVS · Health Care | SGD 143.2B | SGD 368.7B | SGD 195.23 | 2.57% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | SGD 125.4B | SGD 88.3B | SGD 27.64 | 0.66% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SGD 116.2B | SGD 154B | SGD 75.32 | 2.05% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SGD 112B | SGD 232.3B | SGD 134.10 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | SGD 104.7B | SGD 123.8B | SGD 61.74 | 1.56% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | SGD 104B | SGD 221.2B | SGD 50.18 | 1.42% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 52.6B | SGD 58.1B | SGD 49.76 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SGD 52.4B | SGD 123.3B | SGD 1,192.08 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | SGD 48B | SGD 29.4B | SGD 25.67 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SGD 33.1B | SGD 170.4B | SGD 672.20 | 2.94% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | SGD 28.2B | SGD 7.2B | SGD 10.59 | 3.19% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SGD 25.3B | SGD 50.3B | SGD 87.43 | 1.38% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | SGD 20B | SGD 42.4B | SGD 104.30 | 5.59% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | SGD 17.2B | SGD 17B | SGD 33.94 | 1.54% down | 26% up | ||
| 22 | GenmabGMAB · Health Care | SGD 16.6B | SGD 40.9B | SGD 66.30 | 0.75% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 15.1B | SGD 19.6B | SGD 305.27 | 4.57% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | SGD 10.6B | SGD 58.9B | SGD 516.03 | 0.97% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | SGD 10.2B | SGD 30.7B | SGD 721.83 | 3.16% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SGD 9.8B | SGD 15.4B | SGD 79.30 | 0.02% down | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 8B | SGD 16B | SGD 19.15 | 1.00% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | SGD 7.4B | SGD 36.4B | SGD 50.30 | 0.59% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SGD 6.4B | SGD 25.6B | SGD 190.84 | 1.06% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.6B | SGD 27.62 | 2.24% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SGD 4.5B | SGD 5.9B | SGD 35.14 | 0.62% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | SGD 3.7B | SGD 6.3B | SGD 75.30 | 3.16% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | SGD 3.2B | SGD 10B | SGD 59.62 | 1.43% down | 66% up | ||
| 34 | InsmedINSM · Health Care | SGD 2.9B | SGD 40.9B | SGD 186.51 | 20.58% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | SGD 2.2B | SGD 4B | SGD 20.79 | 0.92% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | SGD 2B | SGD 7.4B | SGD 370.45 | 3.94% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | SGD 1.9B | SGD 21.7B | SGD 330.46 | 5.32% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | SGD 1.8B | SGD 9.3B | SGD 66.44 | 0.27% up | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.8B | SGD 8B | SGD 56.35 | 1.25% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.6B | SGD 11.9B | SGD 512.21 | 0.34% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | SGD 1.4B | SGD 12.7B | SGD 83.76 | 1.88% down | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.2B | SGD 11.2B | SGD 401.39 | 1.87% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | SGD 1.2B | SGD 6.2B | SGD 35.81 | 0.25% down | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | SGD 1.2B | SGD 19.7B | SGD 100.93 | 0.22% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | SGD 1.1B | SGD 8B | SGD 123.31 | 3.27% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | SGD 1.1B | SGD 9.2B | SGD 83.89 | 4.15% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | SGD 1B | SGD 7.9B | SGD 194.97 | 3.33% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | SGD 1B | SGD 12B | SGD 126.05 | 3.77% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 985.9M | SGD 9.5B | SGD 120.76 | 1.59% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | SGD 969.8M | SGD 10.9B | SGD 13.65 | 0.67% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | SGD 890.6M | SGD 9.2B | SGD 175.17 | 1.25% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | SGD 862.7M | SGD 10.5B | SGD 160.12 | 2.47% down | 51% up | ||
| 53 | ABIVAXABVX · Health Care | SGD 837M | SGD 9.1B | SGD 104.12 | 3.79% down | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | SGD 781.3M | SGD 6B | SGD 62.36 | 3.86% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | SGD 713.4M | SGD 5.8B | SGD 53.15 | 0.48% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | SGD 685.4M | SGD 6.2B | SGD 109.52 | 1.01% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | SGD 630.8M | SGD 8.5B | SGD 125.97 | 1.91% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 620M | SGD 10.5B | SGD 150.79 | 1.88% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | SGD 568.2M | SGD 5.2B | SGD 38.06 | 1.24% up | 168% up | ||
| 60 | ErascaERAS · Health Care | SGD 511.5M | SGD 6.4B | SGD 18.36 | 3.34% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 197M | SGD 6.8B | SGD 160.59 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2911 SGD).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (SGD 268.7B), Johnson & Johnson (SGD 257.2B) and Sanofi (SGD 181.6B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 22:37 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of SGD 6.41T as of 19 Nov 2026, 22:37 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.